GERON CORP Weighted Average Number of Shares Outstanding, Basic and Diluted
GERON CORP (GERN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 332.07 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- GERON CORP weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 332.07M shares, a 2.60% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 330.87M shares, a 3.67% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 328.93M shares, a 3.18% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 327.03M shares, a 32.42% increase year-over-year.
- GERON CORP weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 327.63M shares, a 20.69% increase from fiscal 2020.
- GERON CORP weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 271.46M shares, a 42.75% increase from fiscal 2019.
- GERON CORP weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 190.16M shares, a 7.74% increase from fiscal 2018.
- GERON CORP weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 176.50M shares, a 10.85% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 332.07M shares 10-Q · filed 2022-05-09 | 331.47M shares derived: average of 2 quarters · filed 2022-05-09 | 330.62M shares derived: average of 3 quarters · filed 2022-05-09 | 329.72M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 330.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 329.90M shares derived: average of 2 quarters · filed 2022-03-10 | 328.94M shares derived: average of 3 quarters · filed 2022-03-10 | 327.63M shares 10-K · filed 2022-03-10 |
| 2021-09-30 | 328.93M shares 10-Q · filed 2021-11-09 | 327.98M shares derived: average of 2 quarters · filed 2021-11-09 | 326.55M shares 10-Q · filed 2021-11-09 | 324.69M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-06-30 | 327.03M shares 10-Q · filed 2021-08-16 | 325.34M shares 10-Q · filed 2021-08-16 | 323.27M shares derived: average of 3 quarters · filed 2022-05-09 | 322.16M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2021-03-31 | 323.64M shares 10-Q · filed 2022-05-09 | 321.40M shares derived: average of 2 quarters · filed 2022-05-09 | 320.53M shares derived: average of 3 quarters · filed 2022-05-09 | 302.14M shares derived: average of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | 319.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 318.98M shares derived: average of 2 quarters · filed 2022-03-10 | 294.97M shares derived: average of 3 quarters · filed 2022-03-10 | 271.46M shares 10-K · filed 2022-03-10 |
| 2020-09-30 | 318.80M shares 10-Q · filed 2021-11-09 | 282.88M shares derived: average of 2 quarters · filed 2021-11-09 | 255.56M shares 10-Q · filed 2021-11-09 | 241.13M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | 246.97M shares 10-Q · filed 2021-08-16 | 223.59M shares 10-Q · filed 2021-08-16 | 215.24M shares derived: average of 3 quarters · filed 2022-03-10 | 208.71M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | 200.22M shares 10-Q · filed 2021-05-10 | 199.38M shares derived: average of 2 quarters · filed 2022-03-10 | 195.96M shares derived: average of 3 quarters · filed 2022-03-10 | 193.61M shares derived: average of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | 198.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 193.83M shares derived: average of 2 quarters · filed 2022-03-10 | 191.41M shares derived: average of 3 quarters · filed 2022-03-10 | 190.16M shares 10-K · filed 2022-03-10 |
| 2019-09-30 | 189.12M shares 10-Q · filed 2020-11-05 | 187.84M shares derived: average of 2 quarters · filed 2020-11-05 | 187.37M shares 10-Q · filed 2020-11-05 | 187.13M shares derived: average of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | 186.56M shares 10-Q · filed 2020-08-06 | 186.48M shares 10-Q · filed 2020-08-06 | 186.47M shares derived: average of 3 quarters · filed 2021-03-11 | 185.93M shares derived: average of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | 186.39M shares 10-Q · filed 2020-05-28 | 186.42M shares derived: average of 2 quarters · filed 2021-03-11 | 185.72M shares derived: average of 3 quarters · filed 2021-03-11 | 182.91M shares derived: average of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | 186.46M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 185.38M shares derived: average of 2 quarters · filed 2021-03-11 | 181.74M shares derived: average of 3 quarters · filed 2021-03-11 | 176.50M shares 10-K · filed 2021-03-11 |
| 2018-09-30 | 184.30M shares 10-Q · filed 2019-11-06 | 179.39M shares derived: average of 2 quarters · filed 2019-11-06 | 173.19M shares 10-Q · filed 2019-11-06 | 169.66M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | 174.48M shares 10-Q · filed 2019-08-01 | 167.54M shares 10-Q · filed 2019-08-01 | 164.78M shares derived: average of 3 quarters · filed 2020-03-12 | 163.39M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | 160.53M shares 10-Q · filed 2019-05-02 | 159.93M shares derived: average of 2 quarters · filed 2020-03-12 | 159.69M shares derived: average of 3 quarters · filed 2020-03-12 | 159.57M shares derived: average of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | 159.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 159.28M shares derived: average of 2 quarters · filed 2020-03-12 | 159.25M shares derived: average of 3 quarters · filed 2020-03-12 | 159.22M shares 10-K · filed 2020-03-12 |
| 2017-09-30 | 159.22M shares 10-Q · filed 2018-11-01 | 159.20M shares derived: average of 2 quarters · filed 2018-11-01 | 159.19M shares 10-Q · filed 2018-11-01 | 159.18M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | 159.18M shares 10-Q · filed 2018-07-31 | 159.17M shares 10-Q · filed 2018-07-31 | 159.16M shares derived: average of 3 quarters · filed 2019-03-07 | 159.16M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | 159.16M shares 10-Q · filed 2018-05-10 | 159.15M shares derived: average of 2 quarters · filed 2019-03-07 | 159.15M shares derived: average of 3 quarters · filed 2019-03-07 | 159.11M shares derived: average of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | 159.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 159.14M shares derived: average of 2 quarters · filed 2019-03-07 | 159.10M shares derived: average of 3 quarters · filed 2019-03-07 | 159.05M shares 10-K · filed 2019-03-07 |
| 2016-09-30 | 159.14M shares 10-Q · filed 2017-11-01 | 159.07M shares derived: average of 2 quarters · filed 2017-11-01 | 159.01M shares 10-Q · filed 2017-11-01 | |
| 2016-06-30 | 159.00M shares 10-Q · filed 2017-08-09 | 158.95M shares 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | 158.90M shares 10-Q · filed 2017-05-09 | |||
| 2015-06-30 | 158.07M shares 10-Q · filed 2016-08-03 | 157.81M shares 10-Q · filed 2016-08-03 | 157.59M shares derived: average of 3 quarters · filed 2016-08-03 | 157.40M shares derived: average of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | 157.55M shares 10-Q · filed 2016-05-05 | 157.35M shares derived: average of 2 quarters · filed 2016-05-05 | 157.18M shares derived: average of 3 quarters · filed 2016-05-05 | 157.06M shares derived: average of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | 157.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 156.99M shares derived: average of 2 quarters · filed 2015-03-11 | 156.90M shares derived: average of 3 quarters · filed 2015-08-05 | 153.54M shares 10-K · filed 2015-03-11 |
| 2014-09-30 | 156.84M shares 10-Q · filed 2014-11-05 | 156.78M shares derived: average of 2 quarters · filed 2015-08-05 | 152.34M shares 10-Q · filed 2014-11-05 | 146.53M shares derived: average of 4 quarters · filed 2015-08-05 |
| 2014-06-30 | 156.71M shares 10-Q · filed 2015-08-05 | 150.09M shares 10-Q · filed 2015-08-05 | 143.09M shares derived: average of 3 quarters · filed 2015-08-05 | 139.39M shares derived: average of 4 quarters · filed 2015-08-05 |
| 2014-03-31 | 143.47M shares 10-Q · filed 2015-05-07 | 136.28M shares derived: average of 2 quarters · filed 2015-05-07 | 133.61M shares derived: average of 3 quarters · filed 2015-05-07 | 132.25M shares derived: average of 4 quarters · filed 2015-05-07 |
| 2013-12-31 | 129.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 128.69M shares derived: average of 2 quarters · filed 2015-03-11 | 128.51M shares derived: average of 3 quarters · filed 2015-03-11 | 128.38M shares 10-K · filed 2015-03-11 |
| 2013-09-30 | 128.29M shares 10-Q · filed 2014-11-05 | 128.23M shares derived: average of 2 quarters · filed 2014-11-05 | 128.15M shares 10-Q · filed 2014-11-05 | 127.93M shares derived: average of 4 quarters · filed 2015-03-11 |
| 2013-06-30 | 128.16M shares 10-Q · filed 2014-08-11 | 128.07M shares 10-Q · filed 2014-08-11 | 127.80M shares derived: average of 3 quarters · filed 2015-03-11 | 127.66M shares derived: average of 4 quarters · filed 2015-03-11 |
| 2013-03-31 | 127.98M shares 10-Q · filed 2014-05-01 | 127.62M shares derived: average of 2 quarters · filed 2015-03-11 | 127.49M shares derived: average of 3 quarters · filed 2015-03-11 | 127.34M shares derived: average of 4 quarters · filed 2015-03-11 |
| 2012-12-31 | 127.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | 127.25M shares derived: average of 2 quarters · filed 2015-03-11 | 127.13M shares derived: average of 3 quarters · filed 2015-03-11 | 126.94M shares 10-K · filed 2015-03-11 |
| 2012-09-30 | 127.24M shares 10-Q · filed 2013-11-07 | 127.06M shares derived: average of 2 quarters · filed 2013-11-07 | 126.83M shares 10-Q · filed 2013-11-07 | 126.44M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | 126.89M shares 10-Q · filed 2013-08-08 | 126.63M shares 10-Q · filed 2013-08-08 | 126.17M shares derived: average of 3 quarters · filed 2014-03-17 | 125.90M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | 126.37M shares 10-Q · filed 2013-05-03 | 125.81M shares derived: average of 2 quarters · filed 2014-03-17 | 125.57M shares derived: average of 3 quarters · filed 2014-03-17 | 125.33M shares derived: average of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | 125.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | 125.17M shares derived: average of 2 quarters · filed 2014-03-17 | 124.98M shares derived: average of 3 quarters · filed 2014-03-17 | 124.51M shares 10-K · filed 2014-03-17 |
| 2011-09-30 | 125.10M shares 10-Q · filed 2012-11-02 | 124.84M shares derived: average of 2 quarters · filed 2012-11-02 | 124.26M shares 10-Q · filed 2012-11-02 | |
| 2011-06-30 | 124.58M shares 10-Q · filed 2012-08-03 | 123.84M shares 10-Q · filed 2012-08-03 | ||
| 2011-03-31 | 123.10M shares 10-Q · filed 2012-05-07 | |||
| 2010-12-31 | 97.60M shares 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |